[ALNY] YoY Quarter Result on 31-Mar-2010 [#Q1]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
06-May-2010
Financial Year
2010
Quarter
31-Mar-2010 [#Q1]
Profit Trend
QoQ- -58.17%
YoY- -56.20%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 CAGR
Revenue 18,642 20,587 20,897 24,564 25,057 22,192 7,217 17.11%
PBT -9,575 -11,368 -16,285 -12,305 -7,224 -1,034 -21,645 -12.69%
Tax -562 -414 -1,802 18 665 205 -2,349 -21.19%
NP -9,013 -11,368 -16,285 -12,323 -7,889 -1,239 -21,645 -13.57%
Tax Rate - - - - - - - -
Total Cost 27,655 31,955 37,182 36,887 32,946 23,431 28,862 -0.70%
Ratio Analysis
31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 CAGR
NP Margin -48.35 -55.22 -77.93 -50.17 -31.48 -5.58 -299.92 -26.20%
Per Share
31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 CAGR
EPS -0.15 -0.25 -0.38 -0.29 -0.19 -0.03 -0.58 -20.16%
EPS Diluted -0.15 -0.25 -0.38 -0.29 -0.19 -0.03 -0.58 -20.16%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.